Kate Hudson
Wall Street is my passion and I love pursuing it but with a pen ! After my Master's in Journalism, I joined Bio Pharma Journal as a freelance writer and was soon promoted to an associate editor position.
Recent Post
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) experienced a remarkable 53.17% spike in its stock price, closing at $3.14 on November 18, 2024, following...
